The government of India won a landmark case earlier this year against the drug’s inventor, Novartis, by rejecting the company’s patent on a crystallised form of the drug, allowing generics to stay on the market. According…
Comment:*
Nickname*
E-mail*
Website
Save my name, email, and website in this browser for the next time I comment.
